²é¿´ÍêÕû°æ±¾: [-- µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© --]

¿¼²©ÂÛ̳ -> µÚËľüÒ½´óѧ -> µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

leagecn 2007-01-20 17:59

µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£©

µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© ~6Fh ,S1?  
%e0X-tXcmX  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© W2h4ej\s  
1.Co-stimulators (or co-stimulating molecules) 7-n HPDp'  
2.NK-kB RU'a 8j+W  
3.Immunoglobulin superfamily 3+d^Bpp 4  
4.antigen-presenting cell (APC) R@5eHP^  
5.death domain F%&lM[N%  
6.CCR and CXCR  4q7H  
7.Lectin (or mitogen) Ja4M@z  
8.Clusters of differentiation, CD) 5 -|7I7(G$  
9.B7 family Qjnh;uBO  
10.Cytotoxic T lymphocyte, CTL) 2Q]W  
11.IL-15 and IL-15 receptor (IL-15R) ^>!&]@  
12.MHC restriction `MCtm(<  
13.Affinity-chromatography ]+a~/  
14.Cyctosprin A, CsA T+E wC)Ll  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) l5 9 N0G  
btnD+O66<  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© I0Allw[  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 F:#5Edo}A  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ dZf1iFCP  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 +cYDz#3%  
\n Wb GS(  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© [_3&  
YIZu{  
ÃâÒßѧרҵ£º bo<.pK$  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ jVOq/o  
40`Qsv0#  
Ïû»¯ÄÚ¿Æ£º J?dz>3Rhx9  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ >?ar  
na9YlJ\  
ѪҺ²¡Ñ§×¨Òµ£º qa@;S,lp  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿


²é¿´ÍêÕû°æ±¾: [-- µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us